Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases. by Rogers, Marc B. et al.
Vol. 37, No. 11ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1993, p. 2391-2400
0066-4804/93/112391-10$02.00/0
Copyright © 1993, American Society for Microbiology
Cloning and Characterization of the Endogenous
Cephalosporinase Gene, cepA, from Bacteroides fragilis
Reveals a New Subgroup of Ambler Class A ,-Lactamases
MARC B. ROGERS,* ANITA C. PARKER, AND C. JEFFREY SMITH
Department ofMicrobiology and Immunology, School ofMedicine,
East Carolina University, Greenville, North Carolina 27858-4354
Received 9 April 1993/Returned for modification 11 June 1993/Accepted 19 August 1993
Bacteroides frgigli& CS30 is a clinical isolate resistant to high concentrations of benzylpenicillin and
cephaloridine but not to cephamycin or penem antibiotics. fl-Lactam resistance is mediated by a chromosom-
ally encoded cephalosporinase produced at a high level. The gene encoding this 13-lactamase was cloned from
genomic libraries constructed in Escherichia coli and then mated with B. fragilis 638 for identification of
ampicillin-resistant (Apr) strains. Apr transconjugants contained a nitrocefin-reactive protein with the physical
and enzymatic properties of the original CS30 isolate. The (3-lactamase gene (cepA) was localized by deletion
analysis and subcloned, and its nucleotide sequence was determined. The 903-bp cepA open reading frame
encoded a 300-amino-acid precursor protein (predicted molecular mass, 34,070 Da). A 13-lactamase-deficient
mutant strain of B. fiugilis 638 was constructed by insertional inactivation with the cepA gene of CS30,
demonstrating strict functional homology between these chromosomal 13-lactamase genes. An extensive
comparison of the CepA protein sequence by alignment with other 13-lactamases revealed the strict
conservation of at least four elements common to Ambler class A. A further comparison of the CepA protein
sequence with protein sequences of (-lactamases from two other Bacteroides species indicated that they
constitute their own distinct subgroup of class A 13-lactamases.
Bacteroides fragilis is responsible for approximately half
of all human anaerobic infections and is the most common
anaerobe recovered from clinical specimens (12). Numerous
reports of B. fragilis isolates resistant to a variety of P-lac-
tam antibiotics indicate that these organisms are becoming
increasingly refractory to treatment with these drugs. The
primary mechanism of 1-lactam resistance in Bacteroides
species is the production of ,B-lactamase (40). At least four
types of P-lactamase have been described for members of
the B. fragilis group, but the most common type is a
constitutively produced, chromosomally encoded cephalos-
porinase having no activity against cefoxitin or imipenem.
This "endogenous" P-lactamase is present in over 90% of
clinical isolates tested (10). Unlike the class C chromosoma-
lly encoded P-lactamases of members of the family Entero-bacteriaceae, the B. fragilis P-lactamase has an isoelectric
point in the acid range and is susceptible to inhibition by
clavulanic acid and sulbactam, placing it in group 2e in the
Bush classification scheme (8).
Regulation of the endogenous B. fragilis j-lactamase has
not been extensively studied, but this enzyme may be
growth rate regulated, with maximal activity occurring 3 h
into the stationary phase (7). With regard to the production
of the endogenous cephalosporinase, others have grouped B.
fragilis clinical isolates into three expression classes (18).
Low-level j-lactamase producers are susceptible to all 3-lac-
tams, the MICs of benzylpenicillin and cephaloridine being
<2 and <16 ,ug/ml, respectively. For intermediate-level
3-lactamase producers, the most frequently encountered
group, the MICs of benzylpenicillin and cephaloridine are 16
and 32 pg/ml, respectively. High-level ,-lactamase produc-
ers are resistant to both drugs at >256 p.g/ml. In all cases, the
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levels of P-lactamase produced correlate closely with MICs
of both cephalosporins and penicillins (18).
In 1977, it was shown that 87% of all B. fragilis strains
tested produced small amounts of the endogenous cephalo-
sporinase constitutively and that 6% produced large amounts
(42). More recent surveys have shown that at least 90% of all
B. fragilis group strains produce (-lactamase and that 25%
produce high levels (10). The existence of these classes and
the increasing frequency of isolation of high-level ,-lacta-
mase-producing strains suggest a trend towards high-level
,-lactamase production in Bacteroides species.
As a first step in identifying possible differences in the
regulation of P-lactamase production between expression
classes, we have cloned and sequenced the chromosomal
cephalosporinase gene (cepA) from a high-level ,3-lactamase-
producing clinical isolate, B. fragilis CS30. In contrast to the
class C chromosomal 1-lactamases of members of the family
Enterobacteriaceae, we present evidence that CepA is a
1-lactamase containing at least four amino acid motifs char-
acteristic of the class A active-site serine 3-lactamases
described by Ambler (1). A comparison of the CepA amino
acid sequence with those of other class A ,B-lactamases,
including two from other Bacteroides species, indicates that
the enzymes from Bacteroides species are most closely
related to each other, forming a distinct homology group that
is significantly different from other class A enzymes.
MATERIALS AND METHODS
Strains and media. The B. fragilis clinical isolates used in
this study are listed in Table 1. B. fragilis 638 (made resistant
to rifampin [47]) and B. uniformis 1001 (MICs of ampicillin
and cephaloridine, 16 and 32 ,ug/ml, respectively) (51) were
the standard recipient strains. Bacteroides strains were
grown at 37°C anaerobically in supplemented brain heart
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TABLE 1. ,-Lactamase activities of and MICs for cefoxitin-susceptible B. fragilis strainsa
B. fragilis MIC (,ug/ml) of: 1-Lactamase activity (U/mg of protein)' against: Origin and yr
strain of originalCephaloridine Ampicillin Nitrocefin Cephaloridine Penicillin G isolation'
CS29 32 8 0.004 0.007 <0.001 PCMH, 1989
CS14 128 16 0.006 0.013 <0.001 PCMH, 1989
638 128 16 0.007 0.015 <0.001 MS, 1974
ATCC 25285 128 32 0.013 0.025 <0.001 ATCC, 1955
CS44 256 32 0.010 0.025 <0.001 PCMH, 1990
RBF49 750 500 0.110 0.86 0.014 URAML, 1979
RBF43 750 500 0.150 0.836 0.009 URAML, 1979
CS30 1,000 750 0.230 1.229 0.012 PCMH, 1990
RBF103 1,250 750 0.270 1.336 0.028 URAML, 1981
a Cefoxitin MICs were <16 ,g/ml. All strains contained a single ,B-lactamase with an isoelectric point of 4.9.
b-Lactamase was measured in crude cell extracts with the indicated substrate. All l-lactamase activities were inhibited by >50% by 1 p,M clavulanate and
1 ,uM cefoxitin.
c PCMH, D. Callihan, Pitt County Memorial Hospital, Greenville, N.C.; ATCC, American Type Culture Collection; URAML, University of Rochester
Anaerobic Microbiology Laboratory; MS, M. Sebald, Pasteur Institute, Paris, France.
infusion broth as described previously (53). Antibiotic MICs
were measured by the standard agar dilution method with
Wilkins-Chalgren agar (Difco Laboratories, Detroit, Mich.).
Values were determined after 48 h of growth. The following
antibiotic concentrations were used unless noted otherwise:
clindamycin, 5 jig/ml; tetracycline, 5 jig/ml; rifampin, 20jig/ml; gentamicin, 25 ,ug/ml; and ampicillin, 50 ,ug/ml.
Escherichia coli DH5aoMCR (F- merA deoR recAl endAl
relAl lac) (GIBCO/BRL, Inc., Gaithersburg, Md.) was
grown aerobically in Luria-Bertani broth (agar) supple-
mented with 50 ,ug of ampicillin per ml, 50 ,ug of spectino-
mycin per ml, or 50 ,ug of kanamycin per ml as appropriate.
Bacterial conjugation. Standard filter mating protocols
were used to transfer plasmids in triparental matings from E.
coli donors to Bacteroides recipients. The E. coli donors
contained helper plasmid RK231, and the filters were incu-
bated aerobically (50).
DNA isolation and analysis. A salt (high concentration)-
sodium dodecyl sulfate (SDS) lysis method was used to
screen Bacteroides strains for plasmid content (61). Purified
plasmid DNA preparations from Bacteroides strains were
obtained by CsCl-ethidium bromide ultracentrifugation of
lysates prepared by alkaline denaturation (53). Genomic
DNAs from Bacteroides strains were prepared as described
previously (55). Screening and large-scale preparations of
plasmid DNAs from E. coli transformants were performed
by the alkaline lysis method (5). Plasmids were analyzed by
agarose gel electrophoresis with Tris-borate or Tris-acetate
buffer containing ethidium bromide. Restriction endonucle-
ase digestion was performed according to supplier instruc-
tions. Other routine DNA manipulations, such as ligation
and Klenow reactions, have been described elsewhere (36).
Southern hybridization analysis was performed on
genomic DNA samples digested with the appropriate restric-
tion endonuclease and electrophoresed on 0.8% agarose
gels. DNA was transferred to nylon membranes (Hybond N;
Amersham Corp., Arlington Heights, Ill.) by either capillary
action or vacuum (Hoefer Scientific Instruments, San Fran-
cisco, Calif.). DNA probes were labeled with 32P by the
random primer reaction with a commercial kit (Pharmacia
LKB, Inc., Piscataway, N.J.). Hybridizations were per-
formed overnight at 670C with 3x SSC (lx SSC is 0.15 M
NaCl plus 15 mM sodium citrate [pH 7.0])-Ax Denhardt's
solution (lx Denhardt's solution contains, per liter, 0.2 g
each of Ficoll 400, polyvinylpyrrolidone, and bovine serum
albumin [Pentex fraction V; Miles Laboratories])-50 ,ug of
yeast RNA per ml. Blots prepared on nylon membranes
were washed in 0.1x SSC-0.1% SDS for 30 min each at
room temperature, 50°C, and 65°C (high stringency). A lower
stringency was achieved by omitting the 65°C wash.
Nucleotide sequence analysis of the cepA gene was per-
formed by first cloning the 2,900-bp BamHI-BglII fragment
of pFD396 into pUC19 and then creating nested sets of
deletions in both orientations as previously described (25).
The forward primer of pUC19 was used in sequencing
reactions with double-stranded DNA templates and modified
T7 polymerase (Sequenase; U.S. Biochemical Corp., Cleve-
land, Ohio). Reaction mixtures were analyzed on 6% poly-
acrylamide gels containing urea.
Library and plasmid constructions. A library of CS30 was
prepared by partial digestion of genomic DNA with Sau3AI.
Fragments were separated on sucrose density gradients, and
fractions of between 5 and 15 kb were isolated, pooled, and
ligated to the BglII site of pJST61.kan (Knr in E. coli strains
and Ccr in Bacteroides strains). This vector was a derivative
of pJST61 (58) in which the bla gene was replaced with a
kanamycin resistance cassette (on a 1,486-bp ClaI fragment)
(59). Ligation mixtures were transformed into E. coli
DH5aMCR. Transformants resistant to 30 jig of kanamycin
per ml were scraped from plates and either flash frozen or
used immediately in aerobic filter matings with B. fragilis
638. Subcloning of the Apr gene was performed with pFD288
(8.8 kb; oriT Spr in E. coli strains and Ccr in Bacteroides
strains [56]). Suicide vector pFD434 was derived from
pFD280 (56) by insertion of the Bacteroides tetQ gene (38)
into the unique SstI site. The construct used for insertional
inactivation of cepA, pFD439, contained the 400-bp HhaI-
EcoRI fragment of cepA (bp 502 to 902) ligated into the SmaI
site of pFD434.
Computer analysis. Computer analysis of nucleotide and
amino acid sequence data was performed with University of
Wisconsin Genetics Computer Group DNA sequence anal-
ysis software (16). The FastA program was used to search
the GenBank-EMBL data base for protein sequences having
similarity to CepA. The Pileup program was used to generate
the progressive multiple alignment of the 1-lactamase pro-
tein sequences. Individual comparisons to the CepA amino
acid sequence were made by use of the GAP program with a
gap weight of 3.0 and a gap length weight of 0.1. The
Testcode program was used to identify protein coding se-
quences within open reading frame (ORF) 1 (ORF1). Phylo-
genetic relationships were inferred from the multiple se-
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quence alignment by the parsimony method with the
PHYLIP phylogeny inference package (version 3.5), and a
consensus tree was constructed from 100 bootstrap esti-
mates of the tree (19).
The cepA nucleotide sequence has been submitted to
GenBank and assigned accession number L13472. Other
sequences used for the analysis, together with their designa-
tions and GenBank accession numbers, are as follows:
Staphylococcus aureus (PC1), M15526 (9); Yersinia entero-
colitica (YER), X57074 (49); Bacillus cereus 13-lactamase III(BCIII), M15195 (29); B. cereus 1-lactamase I (BCI), X06599(52); Actinomadura sp. strain R39 (ACT), X53650 (26);
Streptomyces albus G(ALBUS), M28303 (15); S. aureo-
faciens ,B-lactamase, X13597; E. coli TEM-1 from pBR322(TEM-1), VB0001 (57); B. vulgatus CLA341 (CFXA),
M72418 (45); and B. uniformis 7088 (CBLA), L08472 (54).
Other designations and accession numbers used (see Fig. 5)
are as follows: Klebsiella oxytoca E23004 (KOXY), M27459(4); S. fradiae DSM40063 (FRAD), M34179 (20); K pneu-
moniae LEN-1 (LEN-1), X04515 (3); K ozaenae pBP60-1-2
SHV-2 ,B-lactamase (SHV-2), X53433 (46); B. licheniformis
PenP penicillinase (BLIP), J01545 (37); E. coli RGN238(Tn2603) OXA-1 1-lactamase (OXAl), J02967 (44); Salmo-
nella typhimurium type la R46 OXA-2 3-lactamase (OXA2),
M25261 (14); and Pseudomonas aeruginosa PU21 R151(TnI404) PSE-2 3-lactamase (PSE2), J03427 (27).
Analysis and purification of 13-lactamase. Cell extracts were
prepared by use of a French pressure cell from mid- to
late-logarithmic-phase cells and tested for 3-lactamase activ-
ity with nitrocefin as described previously (41, 45). The
degradation of cephaloridine and benzylpenicillin was deter-
mined by monitoring the decrease at 260 and 233 nm,
respectively (45). Specific activity is expressed as the num-
ber of micromoles of substrate consumed per minute per
milligram of protein. Protein concentrations were deter-
mined by the method of Bradford (6) with bovine serum
albumin as the standard. The cellular location of ,-lactamase
activity was determined by an osmotic shock method as
described previously (45).
Isoelectric focusing was performed by loading cell ex-
tracts onto polyacrylamide gels containing 2% ampholytes at
a pH range of 3.0 to 10.0. Predetermined pI markers were
used as standards. Gels were run at 5°C and 25 W for 1.5 h.
The gradient was measured after electrophoresis by use of a
flat-end surface electrode, and P-lactamases were visualized
by overlaying the polyacrylamide gels with 0.8% agarose in
20 mM sodium phosphate buffer (pH 7.0) containing 50 ,ug of
nitrocefin per ml and photographed with a green filter.
SDS-polyacrylamide gel electrophoresis (PAGE) of pro-
teins was performed as described previously (35). 13-Lacta-
mase proteins were identified in gels by activity staining with
nitrocefin (21, 45). The estimated molecular weight of the
CS30 3-lactamase was determined by SDS-PAGE, by com-
parison with appropriate standards.
The CS30 ,-lactamase was purified as follows. Crude cell
extracts were clarified by centrifugation at 115,000 x g for 2
h (4°C), and the supernatant was applied to a DEAE-Bio-Gel
column (5 by 10 cm; Bio-Rad Laboratories, Richmond,
Calif.). The column was washed with 5 column volumes of
50 mM sodium phosphate buffer (pH 7), and protein was
eluted with a linear 0 to 0.3 M NaCl gradient in the same
buffer. Active fractions were pooled, concentrated by ultra-
filtration (10,000-molecular-weight cutoff), dialyzed against
25 mM histidine-HCl buffer (pH 6.2), and applied to a PBE
94 chromatofocusing column (1 by 42 cm; Pharmacia LKB,
Uppsala, Sweden). The column was developed with pH 4.0
Polybuffer 74-HCl, and active fractions were eluted in the
pH range of 4.6 to 5.2. Active fractions were concentrated as
described above and then dialyzed against 1.4 M NH2SO4 in
0.1 M sodium phosphate buffer (pH 7.2). The resulting
material was applied to a SynChropak Propyl hydrophobic-
interaction high-pressure liquid chromatography column
(250 by 4.6 mm; SynChrom, Inc., Lafayette, Ind.), and
active fractions were eluted with a reverse-phase 2 to 0 M
NH2SO4 gradient. The resulting 13-lactamase fractions were
then pooled and purified to apparent homogeneity by pre-
parative SDS-PAGE on a 10-cm gel (model 491 Prep Cell;
Bio-Rad). The purified protein was submitted to the UCLA
Protein Microsequencing Facility for analysis of the N-ter-
minal amino acid sequence and total amino acid composi-
tion. The total amino acid composition analysis did not
identify tryptophan or cysteine residues and did not differ-
entiate between glutamate and glutamine or aspartate and
asparagine.
RESULTS
Characterization of clinical strains. 3-Lactam MICs and
P-lactamase specific activities were determined for 39 clini-
cal B. fragilis (sensu strictu) strains and compared with those
for the type strain, B. fragilis ATCC 25285. Representative
strains are listed in Table 1. Cell extracts from all of these
strains were able to hydrolyze the cephalosporins nitrocefin
and cephaloridine and displayed only weak activity against
penicillin, indicating that the ,B-lactamases were cephalospo-
rinases. P-Lactamase specific activities ranged from 0.004 to
0.270 (67.5-fold) with nitrocefin as a substrate, and all
P-lactamases were susceptible to inhibition by clavulanate
and cefoxitin, as expected for the Bacteroides endogenous
cephalosporinases. Furthermore the enzymatic activities for
all strains comigrated on SDS gels (mass, 31,500 Da) and
isoelectric focusing gels (pI, 4.9). For both ampicillin and
cephaloridine, there was a high correlation (R = 0.96)
between ,3-lactamase activities and MICs. On the basis of
these strain characteristics, strains were placed into two
expression classes: low (specific activity, 0.004 to 0.013
U/mg of protein) and high (specific activity, 0.110 to 0.270
U/mg of protein). Attempts to induce low-level 3-lactamase-
producing strains to express higher 3-lactamase activities
were unsuccessful, and no spontaneous mutants to a high-
level phenotype were detected.
Cloning of the cephalosporinase gene, cepA. Because anti-
biotic resistance genes from Bacteroides strains are poorly
expressed or are not expressed in E. coli (22), it was
important to use a cloning strategy that would select for the
gene in Bacteroides strains. This was accomplished by use of
a derivative of the positive selection vector pJST61 (58).
pJST61 was modified by replacing the TEM-1 13-lactamase
gene with a kanamycin resistance determinant (59), because
the level of ,B-lactamase activity was high enough to interfere
with the selection of B. fragilis transconjugants. CS30 was
chosen as the source of the DNA, because it produced the
cephalosporinase at a high level, facilitating selection. A
genomic library of approximately 7,650 Knr E. coli colonies
was conjugated with B. fragilis 638, and transconjugants
selected on Wilkins-Chalgren agar containing rifampin, gen-
tamicin, and clindamycin were tested for growth on plates
containing ampicillin (150 ,ug/ml). A total of 24 B. fragilis 638
clones were obtained. The stability of the Apr phenotype
was demonstrated by the ability to be restreaked onto
medium containing rifampin, gentamicin, clindamycin, and
ampicillin (150 ,ug/ml). Several clones were examined in
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FIG. 1. Restriction endonuclease maps of clones containing cepA gene fragments. pFD396 was the original 6.65-kb insert cloned into
pJST61.kan, and all other plasmids were constructed in shuttle vector pFD288 as described in the text. Apr denotes the phenotype of each
plasmid in B. fragilis 638 or B. unifonnis 1001. The junction between the CS30 insert fragment and pJST61.kan is indicated by an asterisk.
The bar under pFD405 represents the location of the cepA ORF. Restriction endonuclease abbreviations: B, BamHI; P, PstI; E, EcoRI; H,
HindIII.
more detail; ,-lactamase specific activities ranged from
0.149 to 0.506 U/mg of protein, and ampicillin MICs for all
the clones were >800 ,ug/ml. Plasmid DNAs from these
clones were isolated, transformed into E. coli, and analyzed
by digestion with Sau3AI. These plasmids shared many
common fragments, and one clone, pFD396, with a 6.65-kb
chromosomal DNA insert, was chosen for further study. E.
coli donors containing pFD396 could transfer the Apr phe-
notype to B. fragilis 638, whereas donors containing
pJST61.kan alone could not confer Apr. The genetic locus
for this P-lactamase gene was designated cepA (cephalospo-
rinase), and the location of this gene within the CS30 DNA
insert is shown in Fig. 1.
Localization of the cepA gene. The B. fragilis cepA gene
was not phenotypically expressed in E. coli; therefore, all
plasmid constructs were first made in E. coli and then
transferred into Bacteroides strains to test for expression.
Partial restriction maps of subfragments cloned from
pFD396 are shown in Fig. 1. Each construct was tested for
the ability to confer Apr to either B. fragilis 638 or B.
unifornis 1001, as measured by selection on Wilkins-Chal-
gren agar containing 300 ,ug of ampicillin per ml. These
experiments revealed that the subcloned gene was unstable
in B. fragilis 638, and deletions often occurred. However,
these subclones were stable in B. unifonmis 1001, which does
not contain a copy of cepA in its chromosome. Constructs
pFD401, pFD403, and pFD404 did not confer Apr, suggest-
ing that an essential portion of the gene was located beyond
the first EcoRI site. The 2,485-bp PstI-BglII fragment, which
encompasses this EcoRI site, was sufficient to confer Apr to
both B. fragilis 638 and B. uniformis 1001.
Evidence that the cloned cepA gene encoded the CS30
P-lactamase was obtained by isoelectric focusing analysis.
Figure 2a shows an isoelectric focusing gel of 1-lactamases
from several cepA clones and B. fragilis CS30, ATCC 25285,
and 638. Each of the wild-type strains showed only a single
nitrocefin-reactive band, and all bands comigrated with a pl
of about 4.9, in agreement with previous studies (43). Strains
containing the cloned gene (lanes B to D) also produced a
P-lactamase focusing at the same pI as the CS30 enzyme.
Although B. fragilis 638 and ATCC 25285 also produced the
endogenous CepA 3-lactamase, the amount produced was
much smaller, and 6- to 20-fold more total protein was
required to visualize an activity band (lanes E and F).
Distribution of cepA among Bacteroides species. The distri-
bution of cepA sequences among other Bacteroides strains
was examined by Southern hybridization analysis. Figure 2b
shows an autoradiograph of a Southern blot containing
chromosomal DNAs from several B. fragilis strains, re-
stricted to completion with EcoRI-HindIII, blotted onto
nylon membranes, and hybridized with a DNA probe en-
compassing the entire cepA structural gene (bp 407 to 1518).
The probe hybridized to chromosomal DNAs from all B.
fragilis strains tested. The B. fragilis strains shown represent
isolates from both 3-lactamase expression classes, as well as
a penicillinase-producing isolate, RBF78 (7), and a cefoxitin-
resistant isolate, V503. In general, members of the low-level
expression class shared common hybridizing fragments of
0.62 and 4.0 kb. For example, B. fragilis CS44, ATCC 25285,
CS14, CS29, BF-2 (55), TM4000 (identical to strain 638), and
V503 (55) shared these two common fragments (with a slight
restriction fragment length polymorphism in the larger BF-2
fragment); members of the high-level expression class also
shared common fragments in addition to the 4.0-kb frag-
ment, but some variations were observed, most notably the
presence of an additional 2.0-kb band and/or a 5.4-kb band.
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FIG. 2. Presence of CepA 3-lactamase and cepA in wild-type
strains of B. fragilis, as detected by isoelectric focusing and South-
em blot analysis. (a) Isoelectric focusing gel (pH 3 to 10) of
Bacteroides cell extracts showing nitrocefin-reactive proteins. The
strain and total amount of protein applied to the gel were as follows:
A, B. fragilis CS30, 8 ,ug; B, B. fragilis 638(pFD396), 16 pg; C,
638(pFD399), 8 pSg; D, B. uniformis lOOl(pFD405), 15 ,g; E, B.
fragilis ATCC 25285, 152 p,g; F, B. fragilis 638, 92 Fg. The arrows
indicate the location of the gradient at which the pH was 4.9. (b)
Autoradiograph of a Southern blot containing Bacteroides chromo-
somal DNAs, illustrating the distribution of cepA among different B.
fragilis strains. Lanes: 1, 638; 2, B. unifonnis 7088; 3, CS30; 4,
RBF43; 5, RBF103; 6, RBF49; 7, CS44; 8, ATCC 25285; 9, CS14;
10, CS29; 11, RBF78; 12, BF-2; 13, TM4000; 14, V503.
There appears to be only one cepA-specific sequence in all of
the B. fragilis strains tested, resulting in two hybridizing
bands due to the internal EcoRI site present in cepA (see
pFD405 in Fig. 1) but only one hybridizing band when an
enzyme that does not digest within the cepA gene is used.
Chromosomal DNAs from other Bacteroides species also
were tested: B. vulgatus WAL 7062, CILA 341, VPI B2-4,
and ATCC 8482; B. uniformis ATCC 8492, 006-1, and 7088;
B. ovatus ATCC 8483, VPI 4244, VPI 3524, and WAL 7606;
B. thetaiotaomicron VPI 11111, ATCC 29148, and ATCC
29741; B. distasonis ATCC 8503; B. eggerthii VPI T3-3; and
B. caccae ATCC 43185. No sequences in these strains
hybridized to the cepA-specific probe at 67°C.
Construction and analysis of a cepA mutant. To establish
the relationship between the cloned cepA gene and the
endogenous B. fragilis P-lactamase, a mutant strain of B.
fragilis 638 was constructed by targeted insertional inactiva-
tion (23) with suicide vector pFD439. A central portion of the
cepA structural gene was used to mediate insertion of the
plasmid into the 638 chromosome via homologous recombi-
nation. All of the Tcr 638 transconjugants were phenotypi-
cally Aps. Integration of the plasmid into the chromosome of
B. fragilis 638 was detected by restricting total DNA with
BglII (which does not cleave pFD439 or cepA) and probing
blots with a 32P-labeled cepA-specific SphI-EcoRI fragment
(bp 247 to 902). In Tcr transconjugants, the hybridizing band
increased in size 7.4 kb relative to that in 638, resulting in a
10.4-kb band in the transconjugants. Other Southern blots
with different restriction endonucleases confirmed these
results. Cell extracts from Tcr transconjugants were exam-
ined on isoelectric focusing gels together with an extract
from B. fragilis 638. The transconjugants failed to display
any nitrocefin-reactive proteins, even when excess protein
was loaded, indicating that they were indeed deficient for
1-lactamase production.
DNA sequence analysis of cepA. The 2,300-bp region of the
CS30 chromosomal insert was sequenced in both directions,
and two ORFs were found (Fig. 3A). No other ORFs larger
than 300 bp were observed in any reading frame. The
assignment of cepA to ORFi is consistent with the subclon-
ing analysis and the results of data base searches described
below.
The nucleotide sequence of the cepA coding region is
shown in Fig. 3B. The moles percent G+C content of the
2,300-bp fragment was 41.6%, and that of the 903-bp cepA
coding region was 40.5%, consistent with the 43% overall
moles percent G+C content of B. fragilis chromosomal
DNA (32). cepA had two possible translational start sites,
ATGs at bp 328 and 436. Statistical analysis of the 2,300-bp
nucleotide sequence was used to determine likely coding
regions by plotting a measure of the nonrandomness of the
sequence at every third base (Testcode [161). With a 95%
level of confidence, the coding region began at bp 436, and
the region between bp 328 and 436 was a noncoding region.
A possible Shine-Dalgarno ribosome-binding site present at
bp 417 to 424 was complementary to the 3' terminus of B.
fragilis 16S rRNA (60) in 6 of 8 bp. On the basis of this
analysis, cepA could encode a protein of 300 amino acids
(34,070 Da). With established criteria (13), a signal peptide
cleavage site after Ala-22 was predicted; this cleavage site
would result in a mature protein of 278 residues with a
predicted molecular mass of 31,562 Da.
Results from an analysis of the CS30 ,B-lactamase agreed
closely with the nucleotide sequence predictions. When
CS30 cells were fractionated, 87% of the total P-lactamase
activity was associated with the periplasmic fraction, the
remaining activity being equally divided between the cyto-
plasmic and extracellular fractions. SDS-PAGE revealed
that this periplasmic ,B-lactamase had a molecular mass of
31,500, and isoelectric focusing gels showed an acid isoelec-
tric point of about 4.9. The purified CS30 1-lactamase had
identical properties, and the total amino acid composition of
the purified protein was very similar to that predicted for
CepA, with a cleavage site at Ala-22. Repeated attempts to
obtain N-terminal sequence data from the protein were not
successful because of extensive acid splitting of the sample.
Although the actual Asp and Asn values were slightly higher
than predicted, the total amino acid composition data for
purified CepA are strong evidence supporting the hypothesis
that cepA is the gene responsible for the production of this
enzyme.
Relationship of CepA to other P-lactamases. GenBank-
EMBL data base searches with the CepA protein sequence
as a query revealed amino acid similarities to 33 different
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cepA or h
1 GATCATGAAGGCCCGGCTGCTGGCCATAGACGATGCCACACTGTTCCCTTTGAAAAGAGAAGAAGCCGTGTTGCTGTTCAAACTGGTCAATGACTTCCAG
101 GAAAGGACATCACTCATCATCACGGCAAACAAGGCACTCACCCGTTGGCTGGAAACATTGGAGGATGAAGCGGTCACAGCCGCCTTGCTTGACAGGCTGC
* .
~~~~~~~sphIi
201 TCTACTGCTGCGAGATTATCAGGCTCGGAGGAACAAGCTATCGCATGCAAAACAGGAAAACAATTTTTAGCAACCAAACACGGATATAGGCACGTAAA
301 AGAGTTAAGGAAAGTGAAGCATCTTCGATGCTGGAGTGGGATATACTAAATTACCTAAAAAAGTGGCGCACAAATTTGCGCGCCACATTATTATTCATAC
Aval ...
401 CTGGACTTAAAACCACTTTCAAAATAAATACATTTCTCGTTTCGCTGATG
S-D M Q KRL I H L STII FF L L C P ALV V A
HhaI .......
501 GCAGAACAGTCCTCTTGAAACTCAACTCAAGAAAGCCATAGAAGGGAAAAAAGCCGAAATAGGAATTGCAGTCATTATCGACGGGCAAGATACGATAACA
Q NS P L E T QL KK A I E GK K AE I G I A V I I DG Q DT I T
601 GTCAATAATGATATTCATTATCCCATGATGAGTGTTTTCAAATTTCATCAGGCATTGGCATTGGCCGATTACATGCATCATCAAAAGCAACCTTTGGAA
V N ND I HYP MM SV F KFH Q ALA L AD Y MH H QKQ P LE T
701 CCCGGTTATTGATTAAAAAGTCGGATTTAAAGCCGGACACCTATAGTCCGCTTCGAGAAACATACCCACAGGGAGGAATCGAAATGAGCATTGCCGA~TC
R L L I K K S D L K P D T Y S P L R E T Y P Q G G I E M S I AD L
Avall
801 ACTGAAATATACGCTTCAGCAAAGTGACAATAATGCCTGCGATATTCTTTTTAATTATCAAGGTGGTCCGGATGCCGTGAATAAGTATCTTCATTCATTG
L K YT L Q Q S D NN AC D I L F NY Q GG P DA VN K YL H S L
EcoRI
901 GATCTATTCGCTCTCGAAGTTCTAATTGGTTTACAATGCATCTACGCCAA
G I RE C A V I H T EN D MH K NL E F C YQ NW T T P L A A AKL
1001 TCGAAATCCAGAACTTGCAGAAAGATCTTTAAATGGATTAAAGCAACCTA
L E I F R N E N L F D K E Y K N F I Y Q T M V E C Q T G Q' D R L I
1101 TCCATCCAAAAGACAGGCTAACGAAGGCGATCAAGCAAACGTCAGCTGGT
A P L L D K K V T MG H K T GTG D R N AK G Q Q I G C N D I G F
1201 ATTCTCGCGCTCTTGAACGCTGGAGTCGACGTAAAAACGGGTACCGATTG
I LL P D G H A YS I A VFV KD SE AD NR E NS ElI I A E I S R
EcoRV .. Clal
1-301 GACTTCATCTAGACGTGTACCAGTTAAATCCTCTTCAACAGCGTAAACGC
I VY E Y V T Q Q I D*
1401 AAAAACGTATTATTGTATGAATCGACGACATTTAACGTTTTTCACTTTTT
FIG. 3. ORFs located in the pFD4O5 insert fragment and nucleotide and protein sequences of the cepA region. (A) Restriction
endonuclease map of the 2,300-bp BglII fragment containing cepA. Major ORFs are depicted as labeled boxes with arrows indicating the
direction of transcription. (B) Nucleotide sequence of the cepA region, with the deduced CepA protein sequence below it. The cepA coding
region begins at bp 436 and terminates at bp 1338, as indicated by an asterisk. The putative ribosome-binding site is underscored and labeled
S-D. The vertical arrow after Ala-22 represents the predicted signal peptide cleavage site. Key restriction endonuclease sites useful for the
isolation of probe fragments are also labeled. The four Ambler class A signature elements (active-site serine residues, the SDN loop, E-166,
and KTG) are shown in boldface type.
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FIG. 4. Deduced amino acid sequence of CepA (CEPA) multiply aligned with sequences of class A ,B-lactamases representing various
homology groups. Numbering is according to Ambler et al. (2) and is based on the PC1 sequence as a reference (9). PC1 secondary structures
involving four or more residues are underlined and labeled al to cxll for a helices and ,13 to 14 for strands (34). Highly conserved regions
are boxed, and previously identified invariant residues (11) are denoted by an asterisk over the sequence. Substitutions in the invariant
residues are underlined and boldfaced. Abbreviations for each sequence are explained in Materials and Methods. The four conserved
elements (34) typical of most class A ,B-lactamases are as follows: element 1 (ABL 70 to 73); element 2 (ABL 130 to 132); element 3 (ABL
166); and element 4 (ABL 234 to 236).
proteins, all of which were 1-lactamases, most belonging to
Ambler class A (1). When class A ,B-lactamases from other
genera were compared individually with CepA, with a sim-
ilarity threshold of <0.5 and minimal gapping (five or fewer
gaps), the amino acid homology ranged from 19.9% identity
(44.7% similarity) for the S. aureofaciens ,B-lactamase to
26.4% identity (49.6% similarity) for the K oxytoca 13-lacta-
mase. Of the six non-Bacteroides sequences aligned to CepA
with five gaps or fewer, four were ,B-lactamases from Strep-
tomyces species. The most striking homology, however, was
to two other chromosomal 1-lactamases from Bacteroides
species. CepA shared 39.9% identity (58.8% similarity) with
the B. vulgatus CLA341 3-lactamase, CfxA (45), and 42.5%
identity (65.8% similarity) with the B. unifornis 7088 1-lac-
tamase, CblA (54). The degree of similarity between CepA
and 13-lactamases of Ambler classes B, C, and D was much
smaller than that between CepA and the class A enzymes, as
more gaps had to be introduced in the comparisons to detect
an overall similarity. For example, the best similarity be-
tween CepA and a class B ,B-lactamase was to the B. cereus
569/H (28) enzyme (26.0% identity and 51.2% similarity with
10 gaps); for class C enzymes, the best similarity was to E.
coli AmpC (31) (19.1% identity and 42.4% similarity with 11
gaps); and for class D enzymes, the OXA-1 1-lactamase of
Tn2603 showed the best similarity (44) (17.4% identity and
38.9% similarity with 6 gaps). Several key features of the
overall protein sequence alignment shown in Fig. 4 clearly
placed CepA in Ambler class A. The alignment was origi-
nally generated with at least two representatives of each
major class A homology group, but five of the sequences
were removed from the figure for clarity. Also included were
the chromosomal 3-lactamases from B. unifonnis and B.
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FIG. 5. Computer-generated homology distance tree illustrating
the relationship among class A P-lactamases, including the Bacte-
roides enzymes and enzymes from class D for comparison. This
unrooted tree was constructed from a multiple alignment similar to
that shown in Fig. 4, except that OXA-1, OXA-2, and PSE-2 (class
D) were included. See Materials and Methods for abbreviations and
accession numbers. The tree topology was obtained by use of the
parsimony program (Protpars) of Felsenstein (19), and the numbers
represent how often the groups of species to the right of a fork
occurred in 100 trees tested. Branch lengths are proportional to the
number of amino acid changes. CEPA, CepA.
vulgatus. Our data agree closely with the extensive align-
ment of Couture et al. (11), which included 26 enzyme
sequences. The four major class A signature elements were
conserved among all of the enzymes (including the Bacte-
roides enzymes), and these were readily identified in our
alignment. These elements included the consensus active-
site serine residues Ser-(X)2-Lys starting at residue Ser-70
(numbering according to Ambler et al. [2]), the SDN loop
starting at Ser-130 (30), the conserved Glu-166 (34), and the
KTG sequence starting at Lys-234 (34).
The phylogenetic relationship between the Bacteroides
enzymes and the other class A ,3-lactamases was visualized
as a dendogram constructed by parsimony analysis of the
multiple alignment and included the class D enzymes for
comparison (Fig. 5). Four subgroups were observed within
the class A enzymes. The TEM-1-LEN-1-SHV-2 subgroup
constitutes the plasmid- or transposon-encoded broad-spec-
trum P-lactamases of gram-negative bacteria; the Actinoma-
dura, Staphylococcus, and Bacillus enzymes form a gram-
positive subgroup; and, surprisingly, the Streptomyces
enzymes are grouped withK oxytoca and Y enterocolitica.
The fourth major subgroup is composed of the three Bacte-
roides enzymes, which were found in all of the bootstrap
replications, clearly establishing a unique homology group
within the realm of Ambler class A ,-lactamases.
DISCUSSION
Recent surveys have shown that over 90% of B. fragilis
group clinical isolates produce a species-specific chromo-
somally encoded 1-lactamase and that 25% of these isolates
produce high levels of this enzyme (10). Others have noted
that isolates can be classified on the basis of the amount of
,B-lactamase produced (specific activity) (18), yet the basis
for the differential expression of this enzyme has not been
studied at the molecular level. On the basis of the criteria of
ampicillin, cephaloridine, and cefoxitin MICs, the ability to
hydrolyze cephaloridine and nitrocefin more rapidly than
benzylpenicillin, the production of a single f-lactamase, and
the P-lactamase isoelectric point, apparent molecular mass,
and inhibition profile, we have described a B. fragilis strain
set producing either high or low levels of this endogenous
cephalosporinase. As a first step towards understanding
,-lactamase expression in Bacteroides strains, we have
cloned the cepA gene responsible for conventional cephalos-
porinase production from a high-level 1-lactamase producer,
CS30.
On the basis of the results of DNA hybridizations with
cepA, the strain set fell into at least two definitive classes,
with all of the low-level producers sharing two common
fragnents. The high-level producers also shared some com-
mon homologous fragments, but there seemed to be greater
variability, depending on the restriction enzyme used for
analysis. Additional evidence that cepA is the structural
gene for the endogenous 3-lactamase in low- and high-level
producers was obtained by constructing a ,-lactamase-
deficient mutant of 638. The ability of the 400-bp internal
portion of the CS30 cepA gene to mediate insertional inac-
tivation of the cepA gene of B. fragilis 638 illustrates the
functional homology of the cepA gene between members of
different expression classes, as well as the dependence of the
Apr phenotype on the presence of a functional copy of cepA.
DNA sequence analysis of the 2,300-bp Sau3AI-BglII
fragment revealed the presence of two ORFs. ORFi (903 bp)
was designated cepA on the basis of its size (ORF2 is only
384 bp) and its striking similarity at the amino acid level to
other 3-lactamases found in the GenBank-EMBL data base.
The 300-amino-acid CepA protein sequence predicted from
the nucleotide sequence closely matched the purified protein
sequence with regard to size and amino acid composition. A
signal peptide cleavage site was predicted after Ala-22; this
cleavage site would result in a mature protein of 278 amino
acids (31,562 Da), a result that agrees well with the 31.5-kDa
nitrocefin-reactive band seen in an SDS-PAGE analysis of
the purified CS30 CepA protein. The predicted pIs of the
pre-3-lactamase and the mature protein were 6.0 and 5.4,
respectively. The pl of purified CepA P-lactamase or crude
extracts of our clinical isolates was 4.9. It is clear that this
value is closer to the predicted value for the mature form,
and there may be charged amino acids buried within the
enzyme that can account for the difference. Others have
reported pIs of 4.9 to 5.4 for the endogenous B. fragilis
enzyme (17, 39).
Other workers have described four conserved elements
(34) and seven "boxes" (33) in alignments of class A
P-lactamases. All three Bacteroides enzymes are identical to
each other with regard to the four elements and to four of the
seven boxes. With regard to individual substitutions of the
25 conserved residues identified by Couture et al. (11), only
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11 of these 25 "invariant" residues are conserved in all three
Bacteroides ,B-lactamases, indicating that these enzymes,
while still maintaining the majority of characteristic class A
elements, have diverged considerably from other class A
enzymes. CepA from B. fragilis CS30 has 12 substitutions of
the 25 invariant residues, and except for the possible con-
servative tyrosine-for-phenylalanine change at residue 67,
none of the substitutions seem strictly conservative. Inter-
estingly, all three Bacteroides enzymes have a threonine
residue substituted for the normally conserved tryptophan
residue (ABL Trp-210 [ABL denotes the standard number-
ing scheme of Ambler et al. (2)]) in box 6. Also of note is the
substitution of a threonine residue in CS30 (ABL Thr-237)
for the normally conserved alanine residue. It is known that
the increased cephalosporinase activity of mutant Hi of the
pBR322 TEM-1 P-lactamase (24) results from a change just
after box 7, whereby Ala-237 (ABL) is replaced by a
threonine residue (33). The f-lactamases of B. vulgatus
CLA341 and B. uniformis 7088 both contain a serine residue
in this position (Ser-237), and both have high cephalospori-
nase activity.
In summary, this work provides the first report of a class
A cephalosporinase from a high-level 3-lactamase-producing
clinical isolate of B. fragilis, CS30. The basis for the in-
creased specific activity in this strain is unknown, but it is
not due to an increase in gene copy number, since only a
single hybridization band appears on Southern blots of total
chromosomal DNA cleaved with an endonuclease that does
not digest within the cepA structural gene (data not shown).
The increase in specific activity is also not due to the
presence of additional ,-lactamases in this strain, as only
one nitrocefin-reactive band can be detected in cell extracts
on isoelectric focusing or SDS-polyacrylamide gels. The
gene appears to be of Bacteroides origin, on the basis of its
moles percent G+C content. We have also shown at the
DNA level that cepA is specific to B. fragilis species,
extending conclusions drawn by others on the basis of the
presence of 1-lactamases with common isoelectric points
(40).
This study also shows the extensive similarity at the amino
acid sequence level of chromosomally encoded ,3-lactamases
from three different Bacteroides species. While others have
shown that P-lactamases from different Bacteroides species
can be differentiated with regard to size, pI, and enzyme
kinetics (17, 43), we show here that at least three of these
P-lactamases share overall similarity in the sense that they
are all class A enzymes and are all more related to each other
than to all other class A ,-lactamases so far discovered.
These results support and extend previous conclusions
drawn about the unique cephalosporinases of Bacteroides
species when antisera made to individual purified endoge-
nous cephalosporinases from B. fragilis, B. vulgatus, and B.
thetaiotaomicron showed some cross-reactivity with one
another but not with antisera made to enzymes from other
genera (48). Furthermore, the phylogenetic analysis clearly
indicates that the Bacteroides enzymes evolved much earlier
than the others, consistent with the taxonomic standing of
the genus (60). In addition, these results suggest that CfxA,
responsible for widespread cefoxitin resistance in Bacte-
roides species (45), clearly evolved from a Bacteroides
,-lactamase gene and was not the result of a recent acquisi-
tion from another species. Future studies will examine at the
DNA level the cepA genes from other high- and low-level
P-lactamase producers, allowing the determination of the
molecular mechanisms that could lead to high-level ,-lacta-
mase production in these clinically important anaerobes.
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